These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16759591)

  • 1. [Antiretroviral treatment associated life-threatening adverse events].
    Moreno-Cuerda VJ; Morales-Conejo M; Rubio R
    Med Clin (Barc); 2006 May; 126(19):744-9. PubMed ID: 16759591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiretroviral-induced toxiderma in HIV-infected patients].
    Caumes E; Bossi P; Katlama C; Bricaire F
    Presse Med; 2003 Sep; 32(28):1325-33. PubMed ID: 14506444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical vignette in antiretroviral therapy: rash illness.
    Zell SC
    J Int Assoc Physicians AIDS Care (Chic); 2003; 2(2):75-80. PubMed ID: 12961761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abacavir-induced reaction with fever and severe skin rash in a patient tested human leukocyte antigen-B*5701 negative.
    Calza L; Rosseti N; Biagetti C; Pocaterra D; Colangeli V; Manfredi R
    Int J STD AIDS; 2009 Apr; 20(4):276-7. PubMed ID: 19304978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety and tolerability of the lamivudine/abacavir combination as components of highly active antiretroviral therapy.
    Castillo SA; Hernandez JE; Brothers CH
    Drug Saf; 2006; 29(9):811-26. PubMed ID: 16944966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blepharoptosis and HAART related mitochondrial myopathy.
    Chapman KO; Lelli G
    Orbit; 2014 Dec; 33(6):459-61. PubMed ID: 25215893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of adverse events to antiretroviral therapy in HIV- infected adults in Ekiti State, Nigeria.
    Popoola TD; Awodele O; Oshikoya KA
    Afr J Med Med Sci; 2016 Jun; 45(2):179-187. PubMed ID: 29465861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens-Johnson syndrome associated with abacavir therapy.
    Bossi P; Roujeau JC; Bricaire F; Caumes E
    Clin Infect Dis; 2002 Oct; 35(7):902. PubMed ID: 12228837
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-nucleoside reverse transcriptase inhibitors (NNRTIs)-induced Stevens-Johnson syndrome and gynecomastia in an HIV-infected child: A case report.
    Saka B; Akakpo AS; Bassowa A; Dapam AN; Mahamadou G; Teclessou JN; Mouhari-Toure A; Laouali AY; Mensah E; Kombaté K; Pitché P
    Ann Dermatol Venereol; 2018 Dec; 145(12):773-776. PubMed ID: 30301570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parsonage-Turner syndrome: a rare case of abacavir hypersensitivity reaction in HIV-infected patients.
    Bellagamba R; Tommasi C; De Marco M; Narciso P
    J Infect; 2008 Jul; 57(1):88-90. PubMed ID: 18514915
    [No Abstract]   [Full Text] [Related]  

  • 11. Abacavir-induced fulminant hepatic failure in a HIV/HCV co-infected patient.
    Haas C; Ziccardi MR; Borgman J
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26670894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular cytokines may model immunoregulation of abacavir hypersensitivity in HIV-infected subjects.
    King D; Tomkins S; Waters A; Easterbrook PJ; Thurmond LM; Thorborn DE; Raffi F; Kemeny DM; Vyakarnam A
    J Allergy Clin Immunol; 2005 May; 115(5):1081-7. PubMed ID: 15867870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abacavir expanded access program for adult patients infected with human immunodeficiency virus type 1.
    Kessler HA; Johnson J; Follansbee S; Sension MG; Mildvan D; Sepulveda GE; Bellos NC; Hetherington SV
    Clin Infect Dis; 2002 Feb; 34(4):535-42. PubMed ID: 11797183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patients.
    Podzamczer D; Imaz A; Perez I; Viciana P; Valencia E; Curto J; Martín T; Castaño M; Rojas J; Espinosa N; Moreno V; Asensi V; Iribarren JA; Clotet B; Force L; Bachiller P; Knobel H; López Bernaldo De Quirós JC; Blanco JR; Rozas N; Vergas J; Ocampo A; Camacho A; Flores J; Gomez-Sirvent JL;
    J Antimicrob Chemother; 2014 Sep; 69(9):2536-40. PubMed ID: 24833755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study.
    Puls RL; Srasuebkul P; Petoumenos K; Boesecke C; Duncombe C; Belloso WH; Molina JM; Li L; Avihingsanon A; Gazzard B; Cooper DA; Emery S;
    Clin Infect Dis; 2010 Oct; 51(7):855-64. PubMed ID: 20735258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.
    Staszewski S; Keiser P; Montaner J; Raffi F; Gathe J; Brotas V; Hicks C; Hammer SM; Cooper D; Johnson M; Tortell S; Cutrell A; Thorborn D; Isaacs R; Hetherington S; Steel H; Spreen W;
    JAMA; 2001 Mar; 285(9):1155-63. PubMed ID: 11231744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abacavir and lamivudine for the treatment of human immunodeficiency virus.
    Rizzardini G; Zucchi P
    Expert Opin Pharmacother; 2011 Sep; 12(13):2129-38. PubMed ID: 21787242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV infected children and adolescents: a systematic review and meta-analysis.
    Adetokunboh OO; Schoonees A; Balogun TA; Wiysonge CS
    BMC Infect Dis; 2015 Oct; 15():469. PubMed ID: 26502899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between abacavir exposure and increased risk for cardiovascular disease in patients with human immunodeficiency virus.
    Schafer JJ; Short WR; Squires KE
    Pharmacotherapy; 2010 Oct; 30(10):1072-83. PubMed ID: 20874044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.
    Gerstoft J; Kirk O; Obel N; Pedersen C; Mathiesen L; Nielsen H; Katzenstein TL; Lundgren JD
    AIDS; 2003 Sep; 17(14):2045-52. PubMed ID: 14502007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.